订阅小程序
旧版功能

OPTIMIZE-1 Primary Analysis: Safety, Efficacy and Biomarker Results of a Phase 1b/2 Study Combining CD40 Agonist Mitazalimab with Mfolfirinox in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma (Mpdac).

Jean-Luc Van Laethem,Ivan Borbath,Karen Paula Geboes,Philippe Alexandre Cassier,Aurelien Lambert,Emmanuel Mitry,Hans Prenen,Lorenzo Pilla,Jean-Frederic Blanc,Inmaculada Gallego Jimenez,Roberto A. Pazo Cid,Mercedes Rodriguez Garrote,Jaime Feliu,Karin Nordbladh,Karin Enell Smith,David Gomez Jimenez,Peter Ellmark, Yago Pico de Coa,Sumeet Vijay Ambarkhane,Teresa Macarulla

Journal of Clinical Oncology（2024）

引用 0|浏览40
关键词
Metastatic Pancreatic Cancer
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要